The balance of activating (CD16, CD32a, CD64) and inhibitory (CD32b) FcγRs on antigen-presenting cells, such as monocytes, determines the response to immune complexes, which are produced abundantly in SLE. The gene discussed is FCGR1A; the disease is systemic lupus erythematosus.